Aleksandr N. Uskov

Aleksandr N. Uskov

Auto-generated profile, based on publicly available information

Aleksandr N. Uskov

Pediatric Research and Clinical Center for Infectious Diseases

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2020 in Pediatric pharmacology
Verified
Journal Article
Open access
PDF file
YAYurii S. Alexandrovich
Yurii S. Alexandrovich
EAEkaterina I. Alekseeva
Ekaterina I. Alekseeva
MBMaya D. Bakradze
Maya D. Bakradze
ABAlexander A. Baranov
Alexander A. Baranov
TBTatiana T. Batysheva
Tatiana T. Batysheva
АЯА. В. Яковлев
А. В. Яковлев
The Ministry of Health of the Russian Federation jointly with professional association and experts in the field of pediatrics, infectious diseases and resuscitation has revised guidelines “Clinical Features and Management of the Disease Caused by New Coronaviral Infection (COVID-19) in Children” in order to provide the child population with effective medical care during the pandemic of the new coronaviral infection. The practical experience of specialists from various countries was considered during the development of this document. Special attention should be given to the evidence base of the presented data, as well as to the efficiency and safety issues of medications used in treatment of coronaviral infection and its complications. The authors highlight the problems of prevention, diagnostics and management of pathological conditions caused by COVID-19 in the article according to the presented guidelines. Patient’s management is presented depending on the age and severity of the disease itself. The therapy is considered with regard to etiological, pathogenetic and symptom focus.

30 March 2021 in Journal Infectology
Verified
Journal Article
Open access
PDF file
YLYu. V. Lobzin
Yu. V. Lobzin
AVAlla Vilnits
Alla Vilnits
Mikhail KostikMikhail Kostik
Mikhail Kostik
MBM. K. Bekhtereva
M. K. Bekhtereva
AUA. N. Uskov
A. N. Uskov
VKV. V. Karasev
V. V. Karasev
С марта 2020 г. появились первые сообщения о возрастающем практически повсеместно количестве детей, перенесших новую короновирусную инфекцию, вызванную SARS-Co2v, с симптомокомплексом, напоминающим проявления болезни Кавасаки. Особенностью клинических проявлений при данном синдроме, который получил название «педиатрический мультисистемный воспалительный синдром, ассоциированный с COVID-19», является высокая частота возникновения жизнеугрожающих состояний, обусловленных резким развитием артериальной гипотензии на фоне кардиогенного или вазогенношого шока. В Санкт-Петербурге с конца декабря 2020 г. наблюдается резкий всплеск поступлений в ОРИТ различных стационаров детей с клиникой педиатрического мультисистемного воспалительного синдрома, имеющих лабораторное подтверждение перенесенного COVID-19. Целью настоящей статьи является привлечение внимания врачей различного профиля для объединения усилий по изучению данной патологии, определения критериев верификации диагноза, оптимальных схем терапии и диспансерного наблюдения за переболевшими.

14 August 2020 in Kuban Scientific Medical Bulletin
Verified
Journal Article
Open access
PDF file
YLYu. V. Lobzin
Yu. V. Lobzin
SRS. V. Rychkova
S. V. Rychkova
AUA. N. Uskov
A. N. Uskov
NSN. V. Skripchenko
N. V. Skripchenko
VFV. V. Fedorov
V. V. Fedorov
The onset of 2020 clearly demonstrated that infection agents pose a major threat to mankind. Current infectiology is shaped by resurrection of “old” seemingly forgotten infections, emergence of “new” infection agents, unusual combinations of known agents, evolving resistance of microorganisms to antibacterial drugs, transformation of human microbiome leading to distortions in herd immunity and, ultimately, emergence of healthcare-related infectious diseases, not letting alone threats of bioterror. Infection agents evolve together with mankind. Novel facets emerge in infectiology, alongside with trends in diagnosis, treatment and prevention of infectious diseases that become more diverse as the list of pathogens grows. Human and infection agent links extend beyond antagonistic relations towards symbiosis. Microorganisms adapt quickly in the new technogenic environment giving rise to novel pathogens and making it unlikely for the mankind to get free from infections any time soon.The total economic damage from infectious diseases increases by year, despite continuous improvement in therapy. Infectious mortality in children aged 0 to 14 years is the top fourth among other causes of death. The work assesses comparative dynamics of “common” childhood infections in the Russian Federation during 2018–2020. We analyse official statistics on paediatric infectious morbidity, comparative dynamics of main infectious diseases (acute respiratory diseases, intestinal infections of bacterial and viral nature, neuroinfections, anthropozoonotic infections, viral hepatitises), assess trends in morbidity of vaccine-preventable infections in children and adults in the Russian Federation, with greater detail towards selected regions, from January 2018 to April 2020.

10 June 2020 in Pediatric pharmacology
Verified
Journal Article
Open access
PDF file
YAYurii S. Alexandrovich
Yurii S. Alexandrovich
EBElena N. Baybarina
Elena N. Baybarina
ABAlexander A. Baranov
Alexander A. Baranov
EVElena A. Vishneva
Elena A. Vishneva
NZNadezda N. Zvereva
Nadezda N. Zvereva
АЯА. В. Яковлев
А. В. Яковлев
The Ministry of Health of the Russian Federation jointly with professional association and experts in the field of pediatrics, infectious diseases and resuscitation has developed guidelines “Clinical Features and Management of the Disease Caused by New Coronaviral Infection (COVID-19) in Children” in order to provide the child population with effective medical care during the pandemic of the new coronaviral infection. The practical experience of specialists from various countries was considered during the development of this document. Special attention should be given to the evidence base of the presented data, as well as to the efficiency and safety issues of medications used in treatment of coronaviral infection and its complications. The authors highlight the problems of prevention, diagnostics and management of pathological conditions caused by COVID-19 in the article according to the presented guidelines. Patient’s management is presented depending on the age and severity of the disease itself. The therapy is considered with regard to etiological, pathogenetic and symptom focus.

1 January 2017 in Pediatric pharmacology
Verified
Journal Article
Open access
PDF file
ARAlla V. Rudakova
Alla V. Rudakova
SKSusanna M. Kharit
Susanna M. Kharit
LLLyudmila V. Lyalina
Lyudmila V. Lyalina
ALAlla S. Lisianskaya
Alla S. Lisianskaya
SPSvetlana A. Protsenko
Svetlana A. Protsenko
СХС. М. Харит
С. М. Харит
Фармакоэкономические аспекты вакцинации против папилломавирусной инфекции девочек-подростков в Российской Федерации

9 December 2022 in Physical and rehabilitation medicine, medical rehabilitation
Verified
Journal Article
Open access
PDF file
EMElena V. Melnikova
Elena V. Melnikova
GIGalina E. Ivanova
Galina E. Ivanova
AUAlexander N. Uskov
Alexander N. Uskov
NSNatalia V. Skripchenko
Natalia V. Skripchenko
NKNina M. Khasanova
Nina M. Khasanova
ЛГЛепихина Татьяна Геннадьевна
Лепихина Татьяна Геннадьевна
BACKGROUND: Solving the issues of rehabilitation of children after lower respiratory tract infections requires putting up rehabilitation diagnoses in the categories of the International Classification of Functioning, Disabilities and Health (ICF). AIMS: The study aimed to define the key problems in the ICF categories and make quantitative and qualitative assessments of the changes in the ICF domains in convalescent children with infectious diseases of the lower respiratory tract at the outpatient stage and in one month after the disease. MATERIALS AND METHODS: The assessment of rehabilitation was performed using the ICF categories for 201 convalescent children with lower respiratory tract infections. RESULTS: Most of the patients had significant impairments in the following functions: b134 Sleep functions; b152 Emotional functions; b280 Feeling of pain; b440 Respiratory functions; b450 Additional respiratory functions; b455 Exercise tolerance function; b460 Sensations associated with cardiovascular and respiratory functions; b730 Muscle strength functions; b740 Muscular endurance functions; b780 Sensations associated with muscles and motor functions, both at the time of discharge from the hospital and a month after the discharge. Environmental factors (e115 Products and technologies for personal use in daily life; e225 Climate; e260 Air quality; e310 Close relatives; e355 Medical workers; e410 Relationships with immediate family members; e450 Relationships with medical workers; e580 Medical services; e585 Services in education and training) were shown to have an influence on rehabilitation process. CONCLUSION: The identified range of functioning disorders and the influence of environmental factors indicates the need for medical rehabilitation for convalescent children with lower respiratory tract infections. The rehabilitation should be multidisciplinary and involve psychological and pedagogical techniques, work with the family, and motor rehabilitation techniques to restore workload tolerance.